Gregory H. Levine
Greg Levine, chair of the FDA regulatory practice group, focuses his practice on FDA regulation of pharmaceuticals, biotechnology and medical devices, regularly representing such clients before state and federal regulators on all phases of the product lifecycle, and assisting with both internal and government compliance investigations and enforcement actions. Greg also advises manufacturers of other FDA-regulated products, including cosmetics and dietary supplements, on a broad range of issues under the Food, Drug, and Cosmetic Act and related laws.
Prior to joining Ropes & Gray, Greg was a partner at an international law firm in Washington, D.C. He is also a former legislative staff member in the U.S. House of Representatives, where he worked on FDA-related legislation, policy, and appropriations.